Skip to main content
  • Regulatory Update

US FDA Transitions COVID-19 Guidance Documents for the End of Public Health Emergency

Drawing of box with FDA logo on it

March 27, 2023

The FDA issued a notice identifying how the agency plans to transition the guidance documents related to COVID-19 once the public health emergency (PHE) ends. Notably, on medical devices, the guidance Policy for Coronavirus Disease-2019 Tests (Revised) and Policy for Evaluating Impact of Viral Mutations on COVID-19 Tests are identified to remain in effect indefinitely. Most device-specific guidances will remain in effect 180 days after the PHE ends for transition.

Emergo by UL will post updates as they become available.

X

Get connected with our sales team

Thanks for your interest in UL's products and services. Let's collect some information so we can connect you with the right person.

Please wait…